The Missouri Supreme Court on Tuesday rejected Johnson & Johnson’s appeal of a $2.12 billion award to women who blamed its baby power for their ovarian cancer.
A state appeals court in June had upheld a St. Louis jury’s 2018 verdict of liability but reduced the award to $2.12 billion from $4.7 billion, saying 17 of the women shouldn’t have been included in the original verdict because they were not Missouri residents.
Johnson & Johnson said Tuesday it plans to appeal to the U.S. Supreme Court, saying the verdict was “fundamentally flawed trial, grounded in a faulty presentation of the facts,” and “at odds with decades of independent scientific evaluations confirming Johnson’s Baby Powder is safe, does not contain asbestos and does not cause cancer,” according to Reuters.
In a Securities and Exchange Commission filing Tuesday, New Jersey-based Johnson & Johnson (NYSE: JNJ) said it will record a $2.1 billion reserve in its 2020 results, citing the verdict. Read More
Recent Comments